Table 3. Drug-related AEs.
Number of patients (%) n = 44 | ||
---|---|---|
Drug-related event | Any grade | Grade ≥ 3 |
Any | 39 (89) | 10 (23) |
Total number of AEs | 151 | 13 |
Infusion-related reactions | 28 (64) | 0 |
Pyrexia | 14 (32) | 0 |
Headache | 7 (16) | 0 |
Coombs indirect test positive | 4 (9) | 0 |
Asthenia | 4 (9) | 2 (5) |
Nausea | 4 (9) | 0 |
Increased alanine aminotransferase | 3 (7) | 2 (5) |
Vomiting | 3 (7) | 0 |
Abdominal pain | 2 (5) | 0 |
Increased blood bilirubin | 2 (5) | 1 (2) |
Decreased appetite | 2 (5) | 0 |
Fatigue | 2 (5) | 0 |
Constipation | 2 (5) | 0 |
Rash | 2 (5) | 0 |
Aseptic meningitis | 2 (5) | 2 (5) |
Abbreviation: AE, adverse event.
Included are drug-related AEs that occurred in at least 2 patients. The other related AEs of grade ≥3 were increased blood lactate dehydrogenase, febrile neutropenia, hemolysis, neutropenia, tumor lysis syndrome, and decreased white blood cell count experienced by 1 patient each (2%).